WuXi Biologics China California

WuXia293Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules.WuXia293Stable platform maintains stable expression and consistent product quality during long-term cell passages, enabling scalable clinical and commercial manufacturing.View original content:https://www.prnewswire.co.uk/news-releases/wuxi-biologics-launches-hek-293-stable-cell-line-platform-wuxia293-stable-for-development-and-manufacturing-of-difficult-to-express-molecules-302526308.html